Speakers

Glenn joined RMCC in 2014 with over 25 years of experience in oncology practice operations and management. He is involved at local, state, and national levels in regards to presenting his knowledge and insight at industry meetings, as well as working with congressional representatives on cancer-related issues. His commitment to making cancer care better at RMCC is demonstrated through his ability to identify, and find solutions to, complex problems. He believes that everyone is an important part of the team at RMCC, and each team member has an equally important role in helping patients through their healthcare journey. Outside of work, he enjoys running, cycling, and skiing and is very proud of the accomplishments of his wife and his two adult children.

Johnetta Blakely is a medical oncologist and hematologist practicing at Tennessee Oncology the largest provider of oncology care in Tennessee.  In April 2024, Dr. Blakely was appointed Executive Vice President of Quality and Clinic Operations, where she oversees clinical programs across over 40 sites, focusing on delivering high-quality, innovative, and patient-centered care. In this leadership role, she also spearheads value-based care initiatives and drives quality improvement efforts throughout the practice. 

Dr. Blakely has been a dedicated member of the Community Oncology Alliance (COA) for years and serves on its Government Affairs Committee, actively contributing to advocacy efforts that shape oncology care policy. Alongside her executive responsibilities, she has maintained a thriving Hematology-Oncology practice for over two decades, with a clinical focus on breast and lung cancers.

She earned her medical degree from the University of Tennessee in Memphis, completed her Internal Medicine residency at the University of Texas in Houston, and pursued a fellowship in Medical Oncology at the University of Texas MD Anderson Cancer Center. Dr. Blakely also holds a Master of Science in Clinical Research from the University of Texas Health Science Center at Houston and a Master of Management in Healthcare from Vanderbilt University.

Dr. Chasky is a physician specializing in Hematology and Medical Oncology. He is a partner at the largest community oncology practice in the greater Philadelphia area and serves on the Board of Directors. He completed a fellowship at Fox Chase Cancer Center in 2008. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Chasky is the Chair of the Clinical Practice Committee at the American Society of Clinical Oncology and the current president of the Pennsylvania Society of Oncology and Hematology. He serves on the Board of Directors of Community Oncology Alliance. Previously, Dr. Chasky served as president of Lower Merion Synagogue in his community from 2020 through 2022.

Dr. Richard McDonough is a board-certified oncologist and hematologist with Florida Cancer Specialists & Research Institute, where he practices near Tampa, Florida. He earned his medical degree from the University of Miami and completed his residency in internal medicine at Jackson Memorial Hospital. He went on to complete a fellowship in hematology and oncology at the Mayo Clinic in Jacksonville, Florida.

With a strong background in clinical research, Dr. McDonough has authored several book chapters, published in numerous peer-reviewed journals, and presented his work at prominent national and international medical meetings.

As Director of Legislative Affairs and Advocacy for Florida Cancer Specialists, Dr. McDonough has become a leading advocate for cancer patients and community oncology. He works tirelessly to ensure that all patients have access to high-quality, affordable cancer care. He previously served as President of the Florida Society of Clinical Oncology (FLASCO) from 2017 to 2019 and as Treasurer from 2014 to 2017.

At the national level, Dr. McDonough actively engages in shaping oncology policy through his work with the Community Oncology Alliance (COA). He serves on multiple COA committees, including as Co-Chair of the Drug Policy Committee. He regularly engages with members of Congress, federal agencies, and industry partners to advance policies that support community oncology practices and protect patient access to care.

Over the past several years, Dr. McDonough has represented his group and colleagues at both the state and national levels, participating in advocacy meetings, legislative summits, and policy retreats. His leadership extends through his service as Chair of the FLASCO Fellows Committee and Nominating Committee and as a member of the FLASCO Executive Committee.

Through his ongoing advocacy and leadership, Dr. McDonough remains deeply committed to strengthening the future of community oncology and the health policy landscape that supports it.

Outside of his professional responsibilities, Dr. McDonough is married and the proud father of three children. He enjoys traveling and is an avid fan of the Tampa Bay Lightning and Florida Gator basketball.

Kathy is a board member of the Community Oncology Alliance, co-chairs the Drug Policy and Regulatory Affairs committee, and serves on their Government Affairs committee. She also serves on the Strategic Advisory Committee and Leadership Council for Flatiron Health and is on the Executive Board for Athena Oncology. Kathy is also a co-chair of the Association of Value-Based Cancer Care and the NCODA Oncology Institute. She is the Associate Editor of Evidence-Based Oncology. Kathy is also a member of ACCC and serves on their Oral Oncolytics Advisory and Government Affairs committees. Additionally, Kathy serves on the editorial boards for The Center for Biosimilars and the Journal of Evidence-Based Managed Care.

Dr. Emily Touloukian is a medical oncologist and hematologist practicing at Coastal Cancer Center in Myrtle Beach, South Carolina. A native of Bloomington, Indiana; she received her undergraduate degree from Pepperdine University and her medical degree from Chicago College of Osteopathic Medicine. She completed her Internship and Residency at Advocate Lutheran General Hospital in Park Ridge, Illinois and subsequently her Fellowship in Hematology/Oncology at Providence Hospital in Southfield, Michigan. Dr. Touloukian is Board Certified by the American Board of Internal Medicine in Medical Oncology, Hematology and Internal Medicine.

In addition to serving as President and CEO of her practice, she is a past President of the South Carolina Oncology Society and the immediate past President of the Medical Society of Horry County. Dr Touloukian is on the Board of Directors on the Community Oncology Alliance (COA) and is the medical co-chair for the COA Patient Advocacy Network. She is on the Board of Directors of OneOncology where she is active in the leadership of the organization. Additionally, she is the immediate past Chair of the ASCO State Affiliate Council and serves as the President of the Board of Directors of the Carolina Cancer Foundation.